Ligand Pharma (LGND) PT Raised to $388 at BofA Securities

July 9, 2026 5:13 AM

BofA Securities analyst Jason Zemansky raised the price target on Ligand Pharma (NASDAQ: LGND) to $388.00 (from $266.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found